These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1938 related articles for article (PubMed ID: 25079328)

  • 61. Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond
    Bakker GJ; Nieuwdorp M
    Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840809
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases.
    Ghavami SB; Rostami E; Sephay AA; Shahrokh S; Balaii H; Aghdaei HA; Zali MR
    Microb Pathog; 2018 Apr; 117():285-289. PubMed ID: 29477743
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of Enteric Protist Blastocystis spp. and Gut Microbiota with Hepatic Encephalopathy.
    Yildiz S; Doğan İ; Doğruman-Al F; Nalbantoğlu U; Üstek D; Sarzhanov F; Yildirim S
    J Gastrointestin Liver Dis; 2016 Dec; 25(4):489-497. PubMed ID: 27981305
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The microbiome of New World vultures.
    Roggenbuck M; Bærholm Schnell I; Blom N; Bælum J; Bertelsen MF; Sicheritz-Pontén T; Sørensen SJ; Gilbert MT; Graves GR; Hansen LH
    Nat Commun; 2014 Nov; 5():5498. PubMed ID: 25423494
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases?
    Berry D; Reinisch W
    Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):47-58. PubMed ID: 23768552
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.
    Remely M; Aumueller E; Merold C; Dworzak S; Hippe B; Zanner J; Pointner A; Brath H; Haslberger AG
    Gene; 2014 Mar; 537(1):85-92. PubMed ID: 24325907
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The human gut microbiome impacts health and disease.
    Ehrlich SD
    C R Biol; 2016; 339(7-8):319-23. PubMed ID: 27236827
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Drugging the gut microbiota: toward rational modulation of bacterial composition in the gut.
    Altamura F; Maurice CF; Castagner B
    Curr Opin Chem Biol; 2020 Jun; 56():10-15. PubMed ID: 31678829
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach.
    Wei X; Yan X; Zou D; Yang Z; Wang X; Liu W; Wang S; Li X; Han J; Huang L; Yuan J
    BMC Gastroenterol; 2013 Dec; 13():175. PubMed ID: 24369878
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comprehensive analysis of the fecal microbiota of healthy Japanese adults reveals a new bacterial lineage associated with a phenotype characterized by a high frequency of bowel movements and a lean body type.
    Oki K; Toyama M; Banno T; Chonan O; Benno Y; Watanabe K
    BMC Microbiol; 2016 Nov; 16(1):284. PubMed ID: 27894251
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis.
    Wen C; Zheng Z; Shao T; Liu L; Xie Z; Le Chatelier E; He Z; Zhong W; Fan Y; Zhang L; Li H; Wu C; Hu C; Xu Q; Zhou J; Cai S; Wang D; Huang Y; Breban M; Qin N; Ehrlich SD
    Genome Biol; 2017 Jul; 18(1):142. PubMed ID: 28750650
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gut microbiota dysbiosis in stable coronary artery disease combined with type 2 diabetes mellitus influences cardiovascular prognosis.
    Tian R; Liu H; Feng S; Wang H; Wang Y; Wang Y; Liang L; Xu H; Xing H; Zhang S
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1454-1466. PubMed ID: 33810955
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children.
    Zhong H; Penders J; Shi Z; Ren H; Cai K; Fang C; Ding Q; Thijs C; Blaak EE; Stehouwer CDA; Xu X; Yang H; Wang J; Wang J; Jonkers DMAE; Masclee AAM; Brix S; Li J; Arts ICW; Kristiansen K
    Microbiome; 2019 Jan; 7(1):2. PubMed ID: 30609941
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular characterisation of the faecal microbiota in patients with type II diabetes.
    Wu X; Ma C; Han L; Nawaz M; Gao F; Zhang X; Yu P; Zhao C; Li L; Zhou A; Wang J; Moore JE; Millar BC; Xu J
    Curr Microbiol; 2010 Jul; 61(1):69-78. PubMed ID: 20087741
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The role of gut microbiota in chronic liver diseases, and treatment possibilities].
    Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G
    Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Linkage of gut microbiome with cognition in hepatic encephalopathy.
    Bajaj JS; Ridlon JM; Hylemon PB; Thacker LR; Heuman DM; Smith S; Sikaroodi M; Gillevet PM
    Am J Physiol Gastrointest Liver Physiol; 2012 Jan; 302(1):G168-75. PubMed ID: 21940902
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
    Schwimmer JB; Johnson JS; Angeles JE; Behling C; Belt PH; Borecki I; Bross C; Durelle J; Goyal NP; Hamilton G; Holtz ML; Lavine JE; Mitreva M; Newton KP; Pan A; Simpson PM; Sirlin CB; Sodergren E; Tyagi R; Yates KP; Weinstock GM; Salzman NH
    Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gut metagenome and spondyloarthritis.
    Schaeverbeke T; Truchetet ME; Richez C
    Joint Bone Spine; 2013 Jul; 80(4):349-52. PubMed ID: 23806346
    [No Abstract]   [Full Text] [Related]  

  • 80. Human microbiome is a diagnostic biomarker in hepatocellular carcinoma.
    Rao BC; Lou JM; Wang WJ; Li A; Cui GY; Yu ZJ; Ren ZG
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):109-115. PubMed ID: 32037278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 97.